Healthcare Innovation in the UK
21 June 2011

A new and sustainable funding model with public sector participation is urgently required for the UK's world class scientists to invent and develop innovative medicines that meet the medical needs of the 21st Century, and contribute to economic growth.
In response to this, the Royal Society of Chemistry has released a position statement detailing the current situation in the pharmaceutical industry and proposing measures that will ensure a strong future for this important sector.
Downloadable Files
A Check-up on Healthcare Innovation
Download the article from RSC News May 2012
PDF (2503k)
Healthcare Innovation in the UK - an Overview
This Overview sets out the background to the Therapeutic Centres of Excellence concept which will be developed in more detail in a subsequent paper that also outline a proposal for precompetitive collaboration in the key area of target validation
PDF (28k)
Healthcare Innovation in the UK: A Royal Society of Chemistry Position paper
An RSC position statement on the current state of the pharmaceutical industry, with recommendations for the future of the sector
PDF (160k)
Supporting Healthcare Innovation
Download the RSC News article on Healthcare Innovation (Sept 2011)
PDF (1035k)
PDF files require
Adobe Acrobat Reader
Contact and Further Information
Dr Ellen Friel
Programme Manager, Life Sciences
Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge CB4 0WF
Tel: +44 (0) 1223 432440
